These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 11386265)

  • 21. Maternal versus paternal inheritance of HLA class I alleles among HIV-infected children: consequences for clinical disease progression.
    Kuhn L; Abrams EJ; Palumbo P; Bulterys M; Aga R; Louie L; Hodge T;
    AIDS; 2004 Jun; 18(9):1281-9. PubMed ID: 15362660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.
    Matthews PC; Koyanagi M; Kløverpris HN; Harndahl M; Stryhn A; Akahoshi T; Gatanaga H; Oka S; Juarez Molina C; Valenzuela Ponce H; Avila Rios S; Cole D; Carlson J; Payne RP; Ogwu A; Bere A; Ndung'u T; Gounder K; Chen F; Riddell L; Luzzi G; Shapiro R; Brander C; Walker B; Sewell AK; Reyes Teran G; Heckerman D; Hunter E; Buus S; Takiguchi M; Goulder PJ
    J Virol; 2012 Dec; 86(23):12643-54. PubMed ID: 22973023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-B*35-PX and HLA-B*35-PY subtype differentiation does not predict observed differences in level of HIV control in a Peruvian MSM cohort.
    Olvera A; Ganoza C; Pérez-Álvarez S; Hildebrand W; Sanchez J; Brander C
    AIDS; 2014 Sep; 28(15):2323-5. PubMed ID: 25313587
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
    Tomiyama H; Miwa K; Shiga H; Moore YI; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
    J Immunol; 1997 May; 158(10):5026-34. PubMed ID: 9144523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA class I alleles associated with susceptibility or resistance to human immunodeficiency virus type 1 infection among a population in Chaco Province, Argentina.
    de Sorrentino AH; Marinic K; Motta P; Sorrentino A; López R; Illiovich E
    J Infect Dis; 2000 Nov; 182(5):1523-6. PubMed ID: 11010837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance of Major Histocompatibility Complex Class B (MHC-B) to Nef-Mediated Downregulation Relative to that of MHC-A Is Conserved among Primate Lentiviruses and Influences Antiviral T Cell Responses in HIV-1-Infected Individuals.
    Mwimanzi F; Toyoda M; Mahiti M; Mann JK; Martin JN; Bangsberg D; Brockman MA; Goulder P; Kirchhoff F; Brumme ZL; Ndung'u T; Ueno T
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations of HLA class I antigen specificities and haplotypes with disease progression in HIV-1-infected Hans in Northern China.
    Zhang H; Zhao B; Han X; Wang Z; Liu B; Lu C; Zhang M; Liu J; Chen O; Hu Q; Jiang F; Shang H
    Hum Immunol; 2013 Dec; 74(12):1636-42. PubMed ID: 24012585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motif inference reveals optimal CTL epitopes presented by HLA class I alleles highly prevalent in southern Africa.
    Honeyborne I; Rathod A; Buchli R; Ramduth D; Moodley E; Rathnavalu P; Chetty S; Day C; Brander C; Hildebrand W; Walker BD; Kiepiela P; Goulder PJ
    J Immunol; 2006 Apr; 176(8):4699-705. PubMed ID: 16585563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major histocompatibility complex class I diversity in a West African chimpanzee population: implications for HIV research.
    de Groot NG; Otting N; Argüello R; Watkins DI; Doxiadis GG; Madrigal JA; Bontrop RE
    Immunogenetics; 2000 May; 51(6):398-409. PubMed ID: 10866106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.
    Kaslow RA; Rivers C; Tang J; Bender TJ; Goepfert PA; El Habib R; Weinhold K; Mulligan MJ;
    J Virol; 2001 Sep; 75(18):8681-9. PubMed ID: 11507213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design.
    Novitsky V; Flores-Villanueva PO; Chigwedere P; Gaolekwe S; Bussman H; Sebetso G; Marlink R; Yunis EJ; Essex M
    Hum Immunol; 2001 Feb; 62(2):146-56. PubMed ID: 11182225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys.
    Voss G; Letvin NL
    J Virol; 1996 Oct; 70(10):7335-40. PubMed ID: 8794394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction.
    Khanna R; Silins SL; Weng Z; Gatchell D; Burrows SR; Cooper L
    Eur J Immunol; 1999 May; 29(5):1587-97. PubMed ID: 10359113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of individual's T-cell immunome in controlling HIV-1 progression.
    Grifoni A; Montesano C; Palma P; Giovanetti M; Castelli-Gattinara G; Ciccozzi M; Mattei M; Mancino G; Salerno A; Colizzi V; Amicosante M
    Immunology; 2014 Dec; 143(4):631-9. PubMed ID: 24954875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide.
    Dong T; Boyd D; Rosenberg W; Alp N; Takiguchi M; McMichael A; Rowland-Jones S
    Eur J Immunol; 1996 Feb; 26(2):335-9. PubMed ID: 8617300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic determinants of HIV-1 infection and progression to AIDS: immune response genes.
    Kaur G; Mehra N
    Tissue Antigens; 2009 Nov; 74(5):373-85. PubMed ID: 19765261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA class I associations with rates of HIV-1 seroconversion and disease progression in the Pumwani Sex Worker Cohort.
    Peterson TA; Kimani J; Wachihi C; Bielawny T; Mendoza L; Thavaneswaran S; Narayansingh MJ; Kariri T; Liang B; Ball TB; Ngugi EN; Plummer FA; Luo M
    Tissue Antigens; 2013 Feb; 81(2):93-107. PubMed ID: 23330720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of HLA polymorphisms on the recognition of Gag epitopes in HIV-1 CRF01_AE infection.
    Sriwanthana B; Mori M; Tanaka M; Nishimura S; Miura T; Pathipvanich P; Sawanpanyalert P; Ariyoshi K
    PLoS One; 2012; 7(7):e41696. PubMed ID: 22848569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allelic heterogeneity of HLA-B35 subtypes in different populations as assessed by DNA typing.
    Satz ML; Fernández-Viña M; Theiler GC; Marcos YC; Lindel N; Capucchio M; Gorodezky C; Fainboim L; Stastny P
    Tissue Antigens; 1995 Sep; 46(3 ( Pt 1)):196-203. PubMed ID: 8525479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalpha.
    Gao GF; Willcox BE; Wyer JR; Boulter JM; O'Callaghan CA; Maenaka K; Stuart DI; Jones EY; Van Der Merwe PA; Bell JI; Jakobsen BK
    J Biol Chem; 2000 May; 275(20):15232-8. PubMed ID: 10809759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.